Cancer Care Ontario | Cancer Care Ontario

16 Results

Guidelines and Advice

Adjuvant Radiotherapy Post-Prostatectomy in T3 or Margin Positive Prostate Cancer

Status: Archived
ID: 3-17
Version: 3

May 2014

Guidelines and Advice

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Status: Education and Information
ID: 7-12 Version 2
Version: 2

May 2013

Guidelines and Advice

Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery

Status: Education and Information
ID: 1-2
Version: 2

Sep 2011

Guidelines and Advice

Adjuvant Radiotherapy in Women with Stage I Endometrial Cancer

Status: Archived
ID: 4-10

Aug 2013

Guidelines and Advice

Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Status: Archived
ID: 5-6c

Nov 2000

Guidelines and Advice

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

Status: Current
ID: GL-7-A-2016-3

Apr 2017

Guidelines and Advice

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Guidelines and Advice

Biodegradable Rectal Spacers for Prostate Cancer Radiotherapy

Status: In-Review
ID: RR 21-5
Version: n/a

Jan 2019

Guidelines and Advice

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Status: In-Review
ID: 3-22
Version: N/A

Apr 2020

Guidelines and Advice

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Status: Current

Apr 2020

Guidelines and Advice

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

Status: Current

Oct 2019

Guidelines and Advice

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Status: Current
ID: GL-END-C50-35

Aug 2023

Adjuvant Radiotherapy Post-Prostatectomy in T3 or Margin Positive Prostate Cancer

Altered Fractionation of Radical Radiation Therapy in the Management of Unresectable Non-Small Cell Lung Cancer

Breast Irradiation in Women with Early Stage Invasive Breast Cancer Following Breast Conserving Surgery

Adjuvant Radiotherapy in Women with Stage I Endometrial Cancer

Accelerated Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non–Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Biodegradable Rectal Spacers for Prostate Cancer Radiotherapy

An Endorsement of the 2018 Guideline on Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline

Best-Practice Guidance for Radiation Treatment Plan Physics Review

Best Practice Guidance for Patient-Specific Quality Assurance for IMRT and VMAT Plan Delivery Verification

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Pages